Mylonib 5mg tabet

Mylonib 5 mg is an anti-cancer drug that consists of an active compound known as Ruxolitinib. Mylonib belongs to the category of Janus Kinase (JAK) inhibitors, which can be used for the treatment of various types of bone marrow conditions, including myelofibrosis and polycythemia vera, along with the acute and chronic graft-versus-host disease (GVHD).Product InformationActive Compound: Ruxolitinib (phosphate) 5 mg per tablet.Company: PharmasolConditions Treated:Intermediate/high-risk myelofibrosis;